← Back to Search

mHealth Application for Living Donor Follow-Up (mHealth Trial)

N/A
Waitlist Available
Led By Macey Henderson, JD, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (≥18 years)
Adults (≥18 years)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

mHealth Trial Summary

This trial will test whether or not using a mobile health application increases the rate of follow-up compliance among living kidney donors.

Who is the study for?
This trial is for adults who have donated a kidney and undergone nephrectomy at Methodist Specialty and Transplant Hospital in San Antonio, Texas or Vanderbilt University Medical Center in Nashville, Tennessee. Participants must consent to the study.Check my eligibility
What is being tested?
The study tests if a mobile health (mHealth) application can improve follow-up compliance among living kidney donors post-donation. Donors are randomly placed into two groups: one uses the mHealth app for follow-ups; the other follows standard care.See study design
What are the potential side effects?
Since this trial involves an mHealth application rather than medication, traditional side effects are not applicable. However, participants may experience issues related to app usability or technical difficulties.

mHealth Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am 18 years old or older.
Select...
I had a kidney removal surgery from a living donor at Methodist Specialty and Transplant Hospital in San Antonio, Texas.
Select...
I had a kidney removal surgery from a living donor at Vanderbilt University Medical Center.
Select...
I had a kidney removal surgery from a living donor at Methodist Specialty and Transplant Hospital in San Antonio, Texas.
Select...
I had a kidney removal surgery from a living donor at Vanderbilt University Medical Center.

mHealth Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
1-year compliance to follow-up
2-year compliance to follow-up
6-month compliance to follow-up
Secondary outcome measures
1-year center follow-up compliance
2-year center follow-up compliance
6-month center follow-up compliance

mHealth Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: mHealth applicationExperimental Treatment1 Intervention
Participants in the intervention arm will receive the mHealth application at their first post-donation clinic visit. Study personnel will assist participants assigned to the mHealth intervention arm with downloading the application and explain its functioning. Participants will then use the application to complete their required 6-month, 1-year, and 2-year follow-up.
Group II: Standard of CareActive Control1 Intervention
The control participants will be instructed to attend required follow-up as is standard of care, and will not receive the mHealth application.

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,338 Previous Clinical Trials
4,313,799 Total Patients Enrolled
Texas Transplant InstituteOTHER
Vanderbilt University Medical CenterOTHER
850 Previous Clinical Trials
668,727 Total Patients Enrolled

Media Library

mHealth application Clinical Trial Eligibility Overview. Trial Name: NCT03400085 — N/A
Living Donors Research Study Groups: Standard of Care, mHealth application
Living Donors Clinical Trial 2023: mHealth application Highlights & Side Effects. Trial Name: NCT03400085 — N/A
mHealth application 2023 Treatment Timeline for Medical Study. Trial Name: NCT03400085 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~45 spots leftby Jan 2025